SEC Tracker
Get the app
MLAB · XBRL financial data

Mesa Laboratories financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (MLAB's year ends in late March)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers53,16553,47358,904*58,17057,83362,84062,135*59,54360,73765,12663,724*60,138
Cost of revenue21,05620,07122,348*20,92122,37823,08623,723*22,60423,40623,33121,519*21,126
Gross profit32,10933,40236,556*37,24935,45539,75438,412*36,93937,33141,79542,205*39,012
Research and development4,9934,2945,202*4,7354,6345,0535,096*4,9845,0485,0295,247*4,725
General and administrative17,52619,43817,843*16,81817,46418,47220,579*17,95817,76318,80524,132*17,384
Total operating expenses32,16933,469307,840*31,66931,94733,97536,943*33,87532,60733,82039,457*31,981
Operating income (loss)(60)(67)(271,284)*5,5803,5085,7791,469*3,0644,7247,9752,748*7,031
Interest expense9051,8561,888*2,8423,0182,8422,519*2,1982,8623,0362,596*2,363
Other income (expense)(360)3,869(2,160)*(2,030)3,322(5,154)1,511*6,146137(343)(1,745)*(315)
Income tax expense (benefit)(95)(170)(20,749)*517384(541)7,575*2,270(477)9662,543*1,523
Net income (loss)(1,230)2,116(254,583)*3,3883,428(1,676)(7,114)*4,7422,4763,630(4,136)*2,830
Earnings per share, basic USD per share(0.23)0.39(47.22)*0.630.63(0.31)(1.31)*0.870.450.66(0.75)*0.50
Earnings per share, diluted USD per share(0.23)0.39(47.24)*0.620.63(0.31)(1.33)*0.850.450.65(0.74)*0.49
Weighted average shares, basic thousands of shares5,3875,3935,392*5,3975,4135,4295,445*5,4655,5125,5325,547*5,657
Weighted average shares, diluted thousands of shares5,3875,3965,389*5,4245,4715,4295,359*5,5535,5355,5655,608*5,757

Balance sheet

CSV

Fiscal quarters (MLAB's year ends in late March)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents35,61728,22428,21428,47224,33730,95627,32121,27920,42228,97526,92830,695
Accounts receivable36,34036,02339,05535,56840,23438,64741,97039,06840,09240,23344,09934,409
Inventory32,87935,97332,67531,76729,73828,12225,36528,10627,73926,55926,37327,229
Prepaid and other current assets12,82618,1359,40810,88313,66913,1208,0299,8059,1809,8658,86810,515
Total current assets117,662118,355109,352106,690107,978110,845102,68598,25897,433105,632106,268102,848
Property and equipment, net28,57431,77531,76631,40232,07331,60232,33331,69231,83531,59930,61330,088
Right-of-use asset——9,671———16,382———17,500—
Goodwill283,268346,183180,096179,722183,753177,152181,760188,050188,488189,303186,863186,038
Total assets637,188741,769446,796440,361454,098437,148433,348435,743430,351434,849427,747419,224
Accounts payable4,8104,5546,0415,6595,9884,0875,7476,2705,0905,2534,9287,459
Accrued liabilities12,33715,89212,85822,48422,86622,35124,60116,07014,22315,54917,61616,536
Total current liabilities39,81644,18344,31254,865153,230155,878163,963149,49448,29554,39561,89857,322
Lease liability, non-current——6,613———12,380———13,66215,852
Total liabilities249,429338,808301,403289,634292,647281,934273,518263,247251,883248,158241,502230,464
Retained earnings (accumulated deficit)70,69971,953(183,494)(180,969)(178,407)(180,952)(188,936)(185,067)(183,473)(180,727)(185,747)(183,801)
Total stockholders' equity387,759402,961145,393150,727161,451155,214159,830172,496178,468186,691186,245188,760
Total liabilities and equity637,188741,769446,796440,361454,098437,148433,348435,743430,351434,849427,747419,224
Common shares outstanding (cover page) thousands of shares5,3925,3945,4095,4095,4315,4345,4555,5015,5225,5255,5255,596

Cash flows

CSV

Fiscal quarters (MLAB's year ends in late March)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(1,230)2,116(254,583)*3,3883,428(1,676)(7,114)*4,7422,4763,630(4,136)*2,830
Stock-based compensation3,183*2,993*2,792*2,9283,837*3,239*3,138*3,8813,812*3,382*6,793*2,359
Depreciation and amortization8,096*———————————
Net cash from operating activities9,776*11,535*12,883*10,4335,271*18,439*12,665*1,8938,222*18,754*13,962*14,736
Purchases of property and equipment634*1,128*535*8911,788*813*757*1,0091,092*732*417*559
Net cash from investing activities(634)*(80,828)*426*(891)(1,788)*(813)*(1,007)*(1,009)(1,092)*(732)*(417)*(559)
Dividends paid862*862*864*863866*869*870*873882*884*884*884
Net cash from financing activities(5,560)*60,848*(12,933)*(9,109)(8,610)*(10,597)*(16,193)*(8,427)(7,883)*(9,785)*(15,759)*(10,498)
Net change in cash3,241*(7,393)*(10)*258(4,135)*6,619*(3,635)*(6,042)(857)*8,553*(2,047)*3,767

Compare with peers

SIC 3823 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3823 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Mesa Laboratories30,69560,13814,7365.6M— 10-QJun 30, 2026
Pacific Biosciences of California61,00339,007(35,583)*310.8M6.7 quarters 10-QJun 30, 2026
Senseonics Holdings44,75314,483(30,138)*52.9M4.7 quarters 10-QJun 30, 2026
Cytek Biosciences73,84648,1401,367*130.0M— 10-QJun 30, 2026
Quantum-Si23,653344(18,444)*not reported6.1 quarters 10-QJun 30, 2026
Crawford United1,923not reported5,706*not reported— 10-QSep 30, 2025
Allient42,088153,77013,954*17.0M— 10-QJun 30, 2026
Frequency Electronics61,40723,4512,62211.3M— 10-QJul 31, 2026
Quanterix44,16932,906(5,119)*47.3M18.3 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.